HVO Hvivo Plc

TIDMVENN

RNS Number : 4096Y

Venn Life Sciences Holdings PLC

03 March 2017

3 March 2017

Venn Life Sciences Holdings Plc

("Venn Life Sciences" or the "Company")

Year End Update

Venn Life Sciences (AIM: VENN), a growing Contract Research Organisation (CRO) providing drug development, clinical trial management and resourcing solutions to pharmaceutical, biotechnology and medical device organisations, today provides the following update.

2016 represented another year of strong growth for Venn with sales in excess of EUR18m (2015 EUR11m). The business finished 2016 with a strong cash position of EUR3m (EUR1.75m 30 June 2016). The strong momentum enjoyed by the business in 2016 has continued into 2017 todate, with new business contracts signed to the value EUR5.7m in the first two months of the year.

Enquiries:

 
Venn Life Sciences Holdings 
 Plc 
 
Tony Richardson, Chief Executive                      Tel: +353 154 99 
 Officer                                                           341 
 
Davy (Nominated Adviser, ESM 
 Adviser and Joint Broker) 
Fergal Meegan / Matthew de Vere                        Tel: +353 1 679 
 White (Corporate Finance)                                        6363 
 
 
Hybridan LLP (Co-Broker) 
Claire Louise Noyce                                Tel: +44(0) 20 3764 
                                                                  2341 
 
Walbrook PR Ltd                          Tel: +44 (0) 20 7933 8787 
                                          or venn@walbrookpr.com 
Paul McManus                                          Mob: +44(0) 7980 
                                                               541 893 
Lianne Cawthorne                                      Mob: +44(0) 7584 
                                                               391 303 
 
 

About Venn Life Sciences:

Venn Life Sciences is a Contract Research Organisation providing drug development, clinical trial management and resourcing solutions to pharmaceutical, biotechnology and medical device organisations. With dedicated operations in France, Germany, the Netherlands, the UK, Ireland and Europe wide representation - Venn specialises in rapid deployment and management of multisite projects.

This information is provided by RNS

The company news service from the London Stock Exchange

END

TSTSSWFWEFWSEID

(END) Dow Jones Newswires

March 03, 2017 02:00 ET (07:00 GMT)

Hvivo (LSE:HVO)
Historical Stock Chart
From Jun 2024 to Jul 2024

Hvivo (LSE:HVO)
Historical Stock Chart
From Jul 2023 to Jul 2024